The most commonly used procedures for the repair of cartilage defects are microfracture, mosaicplasty, osteochondral autologous (or autograft) transplantation system (OATS), and Autologous Chondrocyte Implantation (ACI).
GelrinC is a completely novel treatment option. After standard microfracture, the hydrogel is injected as a liquid, conforming to the lesion size, shape and depth. No cutting or press fitting required to completely fill the lesion.
After short exposure to UVA light, the hydrogel becomes a semi-solid implant tightly integrated with the surrounding tissue and bone with no fibrin glue necessary to secure in place.
The implant acts as a scaffold, gradually eroding over time as new cartilage takes its place. The GelrinC implant completely degrades within 6-12 months.
GelrinC is intended for the repair of focal defects in cartilage and/or osteochondral defects.
Caution: Investigational Device. Limited by U.S. law to investigational use.